v3.26.3
Segment reporting
12 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment reporting

12. Segment reporting

The Company’s operating segments are components of the Company for which separate discrete financial information is available and is evaluated by the Company’s chief operating decision maker (“CODM”), the Chief Executive Officer, in deciding how to allocate resources and assess performance. The Company’s CODM views the Company’s operations and manages its business as a single reportable segment with a single operating segment, which is the business of discovery and development of therapeutic agents in the treatment of genetic disorders.

While the Company has subsidiaries in several geographic regions, there are no standalone operations; rather, all R&D activities are supported by a single corporate team. The determination of a single reportable segment is consistent with the consolidated financial information available and regularly reviewed by the Company’s CODM. The Company manages R&D activities and operating expenses on a consolidated basis.

The CODM uses net loss in making decisions regarding resource allocation and evaluating financial performance, which is also reported on the consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the consolidated balance sheets as total assets.

The following table represents the format for reporting the results of the Company’s reportable segment:

 

(US$’000)

 

June 30,

 

Operating Expenses

 

2026

 

 

2025

 

Research and development

 

$

23,388

 

 

$

18,332

 

General and administrative

 

 

27,804

 

 

 

23,433

 

Other segment items

 

 

(5,646

)

 

 

(3,848

)

Net loss

 

$

(45,546

)

 

$

(37,917

)

 

Other segment items include foreign currency transaction gain (loss), interest income, other expense, net and gain